We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Bacteremia Induced by Debridement of Pressure Ulcer

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00269100
First Posted: December 23, 2005
Last Update Posted: April 20, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Herzog Hospital
  Purpose
The purpose of this study is to analyse bacteremia induced by debridement of pressure ulcers in patients in the complex nursing department.

Condition Phase
Pressure Ulcers Bacteremia Phase 1 Phase 2

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Herzog Hospital:

Estimated Enrollment: 60
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient in the complex nursing department
  • With contaminated pressure ulcers
  • Going to have a debridement procedure

Exclusion Criteria:

  • Penicillin sensitivity
  • Bacteremia that does not react to the antibiotic treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00269100


Locations
Israel
Herzog Hospital
Jerusalem, Israel, 91351
Sponsors and Collaborators
Herzog Hospital
Investigators
Study Director: Efraim Jaul Herzog Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00269100     History of Changes
Other Study ID Numbers: Jaul1CTIL
First Submitted: December 22, 2005
First Posted: December 23, 2005
Last Update Posted: April 20, 2007
Last Verified: April 2007

Keywords provided by Herzog Hospital:
Debridement

Additional relevant MeSH terms:
Bacteremia
Pressure Ulcer
Bacterial Infections
Sepsis
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes
Skin Ulcer
Skin Diseases